BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18448850)

  • 1. Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.
    Ranginwala NA; Hynan LS; Weiner MF; White CL
    Am J Geriatr Psychiatry; 2008 May; 16(5):384-8. PubMed ID: 18448850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
    Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
    Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
    Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the clinical manifestations of Alzheimer disease pathology.
    Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
    Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
    Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
    Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease.
    Holtzer R; Irizarry MC; Sanders J; Hyman BT; Wegesin DJ; Riba A; Brandt J; Albert M; Stern Y
    Arch Neurol; 2006 Feb; 63(2):226-30. PubMed ID: 16476811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular dementia in a population-based autopsy study.
    Knopman DS; Parisi JE; Boeve BF; Cha RH; Apaydin H; Salviati A; Edland SD; Rocca WA
    Arch Neurol; 2003 Apr; 60(4):569-75. PubMed ID: 12707071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample.
    Luis CA; Barker WW; Gajaraj K; Harwood D; Petersen R; Kashuba A; Waters C; Jimison P; Pearl G; Petito C; Dickson D; Duara R
    Int J Geriatr Psychiatry; 1999 Jul; 14(7):526-33. PubMed ID: 10440972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology.
    Oinas M; Sulkava R; Polvikoski T; Kalimo H; Paetau A
    APMIS; 2007 Jul; 115(7):820-7. PubMed ID: 17614849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.
    Bombois S; Maurage CA; Gompel M; Deramecourt V; Mackowiak-Cordoliani MA; Black RS; Lavielle R; Delacourte A; Pasquier F
    Arch Neurol; 2007 Apr; 64(4):583-7. PubMed ID: 17420322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropsychological profile in dementia with Lewy bodies and Alzheimer's disease.
    Oda H; Yamamoto Y; Maeda K
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):125-31. PubMed ID: 18615776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological evaluation of mixed dementia.
    Jellinger KA; Attems J
    J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.
    Joachim CL; Morris JH; Selkoe DJ
    Ann Neurol; 1988 Jul; 24(1):50-6. PubMed ID: 3415200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy bodies and progressive dementia: a critical review and meta-analysis.
    Cercy SP; Bylsma FW
    J Int Neuropsychol Soc; 1997 Mar; 3(2):179-94. PubMed ID: 9126859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias.
    Liscic RM; Storandt M; Cairns NJ; Morris JC
    Arch Neurol; 2007 Apr; 64(4):535-40. PubMed ID: 17420315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
    Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
    Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease.
    Tsuang D; Simpson K; Larson EB; Peskind E; Kukull W; Bowen JB; McCormick W; Teri L; Montine T; Thompson ML; Leverenz JB
    J Geriatr Psychiatry Neurol; 2006 Dec; 19(4):195-201. PubMed ID: 17085757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal lobar degeneration and dementia with Lewy bodies: clinicopathological issues associated with antemortem diagnosis.
    Yokota O
    Psychogeriatrics; 2009 Jun; 9(2):91-102. PubMed ID: 19604332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.